BPH Global LTD (ASX:BP8) is an Asia-Pacific plant-based biotechnology company that is building a food, nutrition, healthcare, cosmetics and personal care business based on plants found in the region, using its proprietary plant genetics and stem cell technology to refine the propagation and cultivation process. BP8’s lead programs involve hemp (which has been cultivated in Asia for millennia), tapping into the medicinal attributes of its cannabidiol (CBD) constituent; and sea grapes (or “green caviar”), a tropical aquatic vegetable native to many parts of the Indo-Pacific coast and a staple delicacy in Japan and regions of south-east Asia; and the processing of these crops to make a wide range of products and additives for the global nutrition, healthcare, cosmetics, beauty, personal care and veterinary markets.

BPH Global LTD (ASX:BP8) is the first foreign company allowed access to the huge China hemp market, while in sea grapes and seaweed, BP8 is building a mass-cultivation aquaculture capability in Singapore, with an integrated manufacturing capacity for high-value products. BP8 is also leveraging its environmentally friendly technology to develop medicinal, health, beauty and anti-ageing applications of several other plants that are familiar components of traditional Chinese medicine (TCM). Also, BP8 has successfully commercialised the processing and production of pharmaceutical grade Resina Draconis product for Asia.